Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,724 public trials 629 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

A Study With Lanadelumab in Persons With Hereditary Angioedema (HAE) in Poland

NCT05147181

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Wielkopolskie Centrum Pulmonologii i Torakochirurgii im. Eugenii i Janusza Zeylandów/Szpital w Poznaniu Poznan, Greater Poland Voivodeship, Poland
  • Szpital Uniwersytecki nr 2 Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
  • Szpital Uniwersytecki w Krakowie Krakow, Lesser Poland Voivodeship, Poland
  • Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu Wroclaw, Lower Silesian Voivodeship, Poland
View all 14 locations
View Trial Details
Completed

Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma

NCT05421598

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • University of California San Diego Health Site Number : 8400026 La Jolla, California, United States
  • California Allergy and Asthma Medical Group, Inc. Site Number : 8400002 Los Angeles, California, United States
  • Allergy Asthma Associates of Santa Clara Valley Site Number : 8400019 San Jose, California, United States
  • Bensch Clinical Research LLC Site Number : 8400004 Stockton, California, United States
View all 113 locations
View Trial Details
Completed

Study in Adult Patients With Moderate to Severe Asthma

NCT04886999

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Chiesi Clinical Trial Site 38011 Bari, Italy
  • Chiesi Clinical Trial Site 38009 Battipaglia, Italy
  • Chiesi Clinical Trial Site 38006 Cagliari, Italy
  • Chiesi Clinical Trial Site 38010 Catanzaro, Italy
View Trial Details
Completed

A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

NCT06224192

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Kern Research Inc Bakersfield, California, United States
  • Long Beach Research Institute Long Beach, California, United States
  • Dermatology Research Associates Los Angeles, California, United States
  • Havana Research Institute Inc Pasadena, California, United States
View all 47 locations
View Trial Details

Related conditions